Regulatory Post-Marketing Surveillance Study for Brolucizumab
Regulatory Post-Marketing Surveillance Study for Brolucizumab
Recruiting · NCT04985487 · Registry updated 2025-01-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Regulatory Post-Marketing Surveillance Study for Brolucizumab | Neovascular Age-related Macular Degeneration | Recruiting | Not stated | 2025-01-14 | NCT04985487 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novartis Pharmaceuticals | 432 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||